The repricing is a modest positive for credit metrics and equity value via lower interest expense. Monitor the next quarterly filing for the actual interest savings and any rating agency action that could trigger the additional 25 bps reduction. The stock may see a small positive reaction, but the event is not transformative — expect a 1-3% move.
Price Chart
Executive Summary
Aveanna Healthcare repriced its first lien credit facility and revolving credit facility, reducing interest rate margins by 50 basis points (with an additional 25 bps reduction contingent on achieving a B2/B credit rating). The amendment refinanced $1.318 billion in term loans and a $250 million revolver at lower spreads (SOFR + 3.25% or base rate + 2.25%). This is a credit-positive event that reduces annual interest expense and improves free cash flow, but it does not change the company's underlying operating performance.
Key Facts
- Repricing reduces interest rate margins by 50 basis points on $1.318 billion in term loans and $250 million revolver
- Additional 25 bps reduction contingent on achieving B2/B credit rating from certain agencies
- New term loans bear interest at SOFR + 3.25% or base rate + 2.25%
- Revolver pricing subject to leverage-based step-downs
- No material changes to other credit agreement terms
Financial Impact
Approximately $6.6 million in annual pre-tax interest savings on the $1.318 billion term loan at the 50 bps reduction, plus potential additional savings from the 25 bps rating-contingent reduction and revolver leverage-based adjustments
Risk Factors
- Rating-dependent margin reduction may not materialize if credit rating is not upgraded to B2/B
- Leverage-based adjustments on the revolver could increase margins if leverage rises
- No change to underlying operational or revenue performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-243028 |
| Document: avah-ex99_1.htm | 0001193125-26-243028 |
| Document: 0001193125-26-243028-index-headers.html | 0001193125-26-243028 |
| Document: 0001193125-26-243028-index.html | 0001193125-26-243028 |
| Document: 0001193125-26-243028.txt | 0001193125-26-243028 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 2, 2026 24d ago | 8-K | $12.37 $12.21 | ▼ −1.29% | ▼ −1.72% | $12.72 (+2.79%) |
Aug 24, 2026 9w ago | Insider Cluster | $13.59 $13.46 | ▲ +0.96% | ▲ +0.42% | $12.72 (+6.44%) |
Aug 24, 2026 9w ago | Insider Cluster | $13.59 $13.46 | ▲ +0.96% | ▲ +0.42% | $12.72 (+6.44%) |
Aug 24, 2026 9w ago | 424B4 | $13.70 $13.42 | ▲ +2.04% | ▲ +2.51% | $12.72 (+7.19%) |
Aug 20, 2026 9w ago | Press Release | $13.16 $13.32 | ▼ −1.22% | ▼ −0.74% | $12.72 (+3.38%) |
Aug 9, 2026 11w ago | Institutional Cluster | $9.46 $12.69 | ▲ +34.14% | ▲ +34.19% | $12.72 (+34.41%) |
Jul 2, 2026 16w ago | Insider Cluster | $9.10 $9.82 | ▼ −7.91% | ▼ −6.98% | $12.72 (−39.73%) |
Jun 30, 2026 16w ago | 144 | $8.86 $9.60 | ▼ −8.35% | ▼ −8.09% | $12.72 (−43.51%) |
Jun 5, 2026 20w ago | Insider Cluster | $6.68 $7.09 | ▼ −6.14% | ▼ −5.57% | $12.72 (−90.34%) |
Jun 3, 2026 20w ago | 144 | $6.63 $7.00 | ▼ −5.58% | ▼ −8.13% | $12.72 (−91.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers